Prevalence of amyotrophic lateral sclerosis in the United States, 2018

Amyotroph Lateral Scler Frontotemporal Degener. 2023 Aug 21:1-7. doi: 10.1080/21678421.2023.2245858. Online ahead of print.

Abstract

Objective: To estimate prevalent ALS cases in the United States for calendar year 2018.

Methods: The National ALS Registry (Registry) compiled data from national administrative databases (from the Centers for Medicare and Medicaid Services, the Veterans Health Administration, and the Veterans Benefits Administration) and enrollment data voluntarily submitted through a web portal (www.cdc.gov/als). We used log-linear capture-recapture (CRC) model-based methodology to estimate the number of cases not ascertained by the Registry.

Results: The Registry identified 21,655 cases of ALS in 2018, with an age-adjusted prevalence of 6.6 per 100,000 U.S. population. When CRC methods were used, an estimated 29,824 cases were identified, for an adjusted prevalence of 9.1 per 100,000 U.S. population. The demographics of cases of ALS did not change from previous year's reports. ALS continues to impact Whites, males, and persons over 50 years of age more so than other comparison groups. The results from the present report suggest case ascertainment for the Registry has improved, with the estimate of missing prevalent cases decreasing from 44% in 2017 to 27% in in 2018.

Discussion: Consistent with previous estimates that used CRC, ALS prevalence in the United States is about 29,824 cases per year.

Keywords: 2018; Amyotrophic lateral sclerosis; National ALS Registry; US; prevalence.